摘要
失眠是一种临床常见的睡眠障碍性疾病。目前,镇静催眠类药物仍然是治疗失眠的主要措施。唑吡坦是一种新型镇静催眠药物,为苯二氮类受体激动剂,属于非苯二氮类。相比苯二氮类,唑吡坦具有治疗失眠安全、有效且长期使用不良反应少的优点,临床应用日益广泛。为了确保合理用药和用药安全,临床医师和药师应基于相关指南,正确选择适应证,严密监测药物不良反应,加强精神药品应用管理,防止镇静催眠药物滥用。
Insomnia is a common sleep disorder, at present, sedative and hypnotic drugs are still the main measures in the treatment of insomnia. Zolpidem is benzodiazepine receptor agonists, which is a new type of sedative and hypnotic drugs, belonging to the nonbenzodiazepine drugs. Compared to benzodiazepine drugs in the treatment of insomnia, Zolpidem has the advantages of safe and effective, less adverse reactions, widely clinical application. In order to ensure the rational use of drugs and medication safety, clinicians and pharmacists should base on the relevant guidelines, correctly select indications, closely monitor adverse drug reactions, strengthen the management of psychotropic drugs, and prevent the abuse of sedative and hypnotic drugs.
作者
刘桂萍
张国领
LIU Gulping ZHANG Guoling(Department of Outpatient, 309th Hospital of PLA, Beijing 100082, China)
出处
《中国医药导报》
CAS
2017年第29期41-44,共4页
China Medical Herald
关键词
睡眠障碍
失眠
唑吡坦
临床应用
合理用药
Sleep disorders
Insomnia
Zolpidem
Clinical application
Rational drug use
